BeOne Medicines AG at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm a large cap biotech analyst at JPMorgan, and we're continuing the 44th Annual Healthcare Conference today with BeOne. First, you're going to hear a presentation from the company, and then we're going to go into a little Q&A.
If you are in the room, raise your hand, we can pass you a mic. And if you're listening online, you can always submit questions to the portal.
But with that out of the way, let me pass it over to the company's Co-Founder, Chair, and CEO, John Oyler.
Great. Thank you so much, Jess, and thank you all for being here. It's interesting, 44 years. I think I've been coming for about 25, and I really want to say how proud I am of the industry that it's made such an impact in our fight against cancer. Over this time across a broad range of cancers, the impact on overall five-year survival has been meaningful and dramatic,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
